Our findings unveil a PD-1–mitochondria–senescence axis in CD4+T cells, offering novel therapeutic strategies to target pathogenic senescent T cells in RA and redefining the functional role of PD-1 signaling in RA pathophysiology. Here, CD4 is linked to rheumatoid arthritis.